This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia
Scientific Reports Open Access 07 August 2018
-
Prognostic signature and clonality pattern of recurrently mutated genes in inactive chronic lymphocytic leukemia
Blood Cancer Journal Open Access 28 August 2015
-
NOTCH1 mutations influence survival in chronic lymphocytic leukemia patients
BMC Cancer Open Access 04 June 2013
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910–1916.
Gunnarsson R, Isaksson A, Mansouri M, Goransson H, Jansson M, Cahill N et al. Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients. Leukemia 2010; 24: 211–215.
Zenz T, Eichhorst B, Busch R, Denzel T, Habe S, Winkler D et al. TP53 mutation and survival in chronic lymphocytic leukemia. J Clin Oncol 2010; 28: 4473–4479.
Fabbri G, Rasi S, Rossi D, Trifonov V, Khiabanian H, Ma J et al. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J Exp Med 2011; 208: 1389–1401.
Puente XS, Pinyol M, Quesada V, Conde L, Ordonez GR, Villamor N et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 2011; 475: 101–105.
Rossi D, Bruscaggin A, Spina V, Rasi S, Khiabanian H, Messina M et al. Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness. Blood 2011; 118: 6904–6908.
Wang L, Lawrence MS, Wan Y, Stojanov P, Sougnez C, Stevenson K et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med 2011; 365: 2497–2506.
Quesada V, Conde L, Villamor N, Ordonez GR, Jares P, Bassaganyas L et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 2012; 44: 47–52.
Rossi D, Fangazio M, Rasi S, Vaisitti T, Monti S, Cresta S et al. Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia. Blood 2012; 119: 2854–2862.
Rossi D, Rasi S, Fabbri G, Spina V, Fangazio M, Forconi F et al. Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. Blood 2012; 119: 521–529.
Balatti V, Lerner S, Rizzotto L, Rassenti LZ, Bottoni A, Palamarchuk A et al. Trisomy 12 CLLs progress through NOTCH1 mutations. Leukemia 2012; e-pub ahead of print 20 August 2012; doi: 10.1038/leu.2012.239.
Del Giudice I, Rossi D, Chiaretti S, Marinelli M, Tavolaro S, Gabrielli S et al. NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL. Haematologica 2012; 97: 437–441.
Lopez C, Delgado J, Costa D, Conde L, Ghita G, Villamor N et al. Different distribution of NOTCH1 mutations in chronic lymphocytic leukemia with isolated trisomy 12 or associated with other chromosomal alterations. Genes Chromosomes Cancer 2012; 51: 881–889.
Zainuddin N, Murray F, Kanduri M, Gunnarsson R, Smedby KE, Enblad G et al. TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia. Leuk Res 2011; 35: 272–274.
Smedby KE, Hjalgrim H, Melbye M, Torrang A, Rostgaard K, Munksgaard L et al. Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 2005; 97: 199–209.
Acknowledgements
This research was supported by the Nordic Cancer Union, the Swedish Cancer Society, the Swedish Research Council and the Lion’s Cancer Research Foundation, Uppsala.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Mansouri, L., Cahill, N., Gunnarsson, R. et al. NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemia. Leukemia 27, 512–514 (2013). https://doi.org/10.1038/leu.2012.307
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2012.307
This article is cited by
-
Chronic lymphocytic leukaemia: from genetics to treatment
Nature Reviews Clinical Oncology (2019)
-
Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia
Scientific Reports (2018)
-
Prognostic signature and clonality pattern of recurrently mutated genes in inactive chronic lymphocytic leukemia
Blood Cancer Journal (2015)
-
Molecular basis of chronic lymphocytic leukemia diagnosis and prognosis
Cellular Oncology (2015)
-
Molecular pathogenesis of CLL and its evolution
International Journal of Hematology (2015)